Skip to main content
Fig. 6 | Journal of Experimental & Clinical Cancer Research

Fig. 6

From: The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells

Fig. 6

The combination of palbociclib with BEZ235 enhances cell death. MDA-MB-231 cells were treated with 0.5 μM palbociclib, 50 nM BEZ235 or with three schedules of treatments: simultaneous, sequential or sequential combined. After 72 h, cell proliferation was evaluated by cell counting with trypan blue exclusion (a) and cell death was assessed by fluorescence microscopy after Hoechst 3342/PI staining (b). Results are representative of three independent experiments (n = 5). ***p < 0.001 vs ctrl; #p < 0.05, ###p < 0.001 vs palb; §p < 0.05, §§§p < 0.001 vs BEZ235; ▪▪▪p < 0.001 vs P + BEZ235; p < 0.001 vs P➔BEZ235

Back to article page